Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 1,151–1,175 of 27,380 studies, newest first · page 47 of 1096.

June 2026 16

  1. 2026-06-01

    Nonpharmacological multicomponent intervention for mild cognitive impairment with a family-patient approach: protocol for the pilot clinical trial—INTERCOG study

    ✓ Peer-reviewed Mild cognitive impairment PubMed Central

    Key finding: Multicomponent and transdisciplinary interventions focused on the family member–patient dyad have the potential to optimize cognitive outcomes and quality of life.

  2. 2026-06-01

    Lewy Bodies Are Not Associated With Neuronal or Synaptic Loss in Dementia With Lewy Bodies

    ✓ Peer-reviewed Lewy body dementia Neuropathology and Applied Neurobiology

    Key finding: Across both regions, no evidence of reduced total neuronal density was observed, but a modest reduction in parvalbumin interneurons was observed in the cingulate gyrus, and there were only modest reductions in some synaptic markers in DLB. +3 more findings

  3. 2026-06-01
  4. 2026-06-01

    From Hearing Aid Uptake to Hearing Aid Effectiveness: Rethinking Dementia Risk Reduction in Adults With Hearing Loss

    ✓ Peer-reviewed Prevention and risk Sensory Neuroscience

    Key finding: Hearing aid use was associated with a modestly lower risk of probable dementia overall (Hazard Ratios, HR, 0.91), but the association was confined to participants reporting improvements in hearing (HR 0.86), with no apparent benefit among those reporting poor improvement in hearing (HR 0.98). +1 more finding

  5. 2026-06-01

    Lecanemab: Wirksamkeit beruht auf dem Fc-Fragment des Antikörpers

    ✓ Peer-reviewed Treatments Fortschritte der Neurologie · Psychiatrie

    Key finding: Lecanemab ist eine Anti-Amyloid-Antikörper-Therapie, die entwickelt wurde, um toxische Amyloid-Plaques zu beseitigen und das Fortschreiten der Alzheimer-Krankheit zu verlangsamen. +3 more findings

  6. 2026-06-01

    Evaluation of the relationships between inflammatory markers and processing speed in recent-onset and chronic schizophrenia: a polygenic risk score study

    ✓ Peer-reviewed Genetics European Psychiatry

    Key finding: Hierarchical linear regression was used to assess an incremental contribution of the set of inflammatory markers’ PRS to explaining VF variance compared to the null model. +4 more findings

  7. 2026-06-01

    Porphyromonas gingivalis disrupts hippocampal circadian clock via PI3K/AKT pathway, exacerbating Alzheimer‐like pathology

    ✓ Peer-reviewed Biomarkers Alzheimer s & Dementia

    Key finding: P. gingivalis-induced periodontitis dampened hippocampal Bmal1 rhythms, lowered p-AKT, activated glia, and elevated Aβ and interleukin 1β (IL-1β). +3 more findings

  8. 2026-06-01

    Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio

    ✓ Peer-reviewed Biomarkers JAMA Neurology

    Key finding: This cross-sectional study evaluates the performance of the US Food and Drug Administration–cleared phosphorylated tau 217 (p-tau217) to β-amyloid 42 ratio cut points used to detect amyloid pathology associated with Alzheimer disease.

  9. 2026-06-01

    Meeting the mental health needs of people with the complex neurodevelopment condition, Prader-Willi syndrome: a major challenge for mental health services

    ✓ Peer-reviewed Risk factors European Psychiatry

    Key finding: The behavioural and mental health needs of people with PWS result from the interactions between biological vulnerabilities associated with having PWS and living in a changing and demanding environment. +3 more findings

  10. 2026-06-01

    Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study

    ✓ Peer-reviewed Tau biomarkers The Lancet. Neurology

    Key finding: Individuals with autosomal dominant Alzheimer's disease (ADAD) arising from mutations in PSEN1, PSEN2, or APP exhibit variability in clinical presentation. +3 more findings

  11. 2026-06-01

    Imaging and plasma biomarkers for pathological accumulation in Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Brain : a journal of neurology

    Key finding: These results suggest that all adults with Down syndrome should be screened for Alzheimer's disease pathology starting shortly before age 40 years and considered for clinical trials.

  12. 2026-06-01
  13. 2026-06 month only

    Efficacy of a language-concordant community health worker intervention to improve community-to-clinic linkage for dementia care: results of the randomized trial PLAN

    ✓ Peer-reviewed Caregiving Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Longer follow-up and testing across diverse LEP communities are needed to assess diagnosis, treatment initiation, and caregiver trajectories.

  14. 2026-06-01

    Diet Quality and Dementia Risk in Older Adults With Alzheimer Pathology

    ✓ Peer-reviewed Prevention and risk JAMA Network Open

    Key finding: Over a mean follow-up of 8.4 years (range, Conclusions and relevance This cohort study of older adults found that adherence to a dietary pattern with lower inflammatory potential was associated with lower dementia risk among individuals with AD pathology and broader neurobiological risk. +2 more findings

  15. 2026-06-01

    Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study

    ✓ Peer-reviewed Prevention and risk JAMA Neurology

    Key finding: This study found that a high-intensity multidomain lifestyle intervention did not affect brain biomarker trajectories and was not associated with Aβ pathology, but older adults with specific at-risk brain characteristics, including lower baseline HC volume, showed a greater cognitive benefit of the structured intervention. +3 more findings

  16. 2026-06-01

    Benefits and Harms of Dementia Screening for Family Members of Older Adults: A Randomized Clinical Trial

    ✓ Peer-reviewed Getting a diagnosis JAMA Internal Medicine

    Key finding: This randomized clinical trial found that ADRD screening in PC was not associated with improvement in family member health-related quality of life, caregiver preparedness, or caregiving self-efficacy. +4 more findings

May 2026 9

  1. 2026-05-31

    Neighborhood disadvantage and cognitive function in older adults: The moderating role of young adult general cognitive ability

    ✓ Peer-reviewed Risk factors Health & Place

    Key finding: Neighborhood disadvantage in later life is associated with poorer cognition and increased vulnerability to dementia. +1 more finding

  2. 2026-05-31

    Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia

    ✓ Peer-reviewed Health systems and care delivery JAMA Health Forum

    Key finding: The study cohort included 1 415 265 long-stay nursing home residents with dementia who died between 2013 and 2022. +4 more findings

  3. 2026-05-30

    Association of plasma glial fibrillary acidic protein and neurofilament light chain with retinal cell layer thickness: A cross-sectional study of ophthalmic surgical patients

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: BackgroundRetinal thickness has been associated with neurocognitive conditions such as Alzheimer's disease (AD).ObjectiveRetinal cell layer thickness was evaluated for associations with neurodegenerative protein biomarkers glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) in plasma, vitreous humor, and aqueous humor. +4 more findings

  4. 2026-05-30
  5. 2026-05-29

    Dementia diagnostic deserts: workforce and geographic inequities in the diagnostic pathway for cognitive impairment

    ✓ Peer-reviewed Health systems and care delivery Health affairs scholar

    Key finding: Nurse practitioners and physician assistants are frontline providers in these underserved regions but face significant training gaps and practice-level infrastructure barriers.

  6. 2026-05-29

    Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD

    ✓ Peer-reviewed Inflammation and the immune system Journal of Neuroinflammation

    Key finding: Across diverse viral infections, strong convergence was observed in innate immune activation pathways, including microglial priming and NLRP3 inflammasome signaling, accompanied by chronic production of proinflammatory cytokines (IL-1β, TNF-α, IFN-γ). +4 more findings

  7. 2026-05-29

    Assessing the de novo paradigm in sporadic early-onset Alzheimer disease trios

    ✓ Peer-reviewed Genetics Molecular Psychiatry

    Key finding: No significant burden of rare coding variants in exome/genome data from 5643 EOAD cases and 16097 controls was identified using nested windows centered on each DNM position, at the transcript level. +1 more finding

  8. 2026-05-29

    Associations between Alzheimer's disease blood biomarkers and neighborhood disadvantage: A HABS-HD community cohort study

    ✓ Peer-reviewed Risk factors Journal of Alzheimer s Disease

    Key finding: BackgroundNeighborhood disadvantage has been associated with reduced cognitive reserve, increased risk for cognitive impairment, and greater Alzheimer's disease (AD) neuropathology, with particularly pronounced effects among Black and Hispanic/Latino older adults. +3 more findings

  9. 2026-05-29

    Association of residential neighborhood disadvantage with amyloid PET positivity among cognitively impaired individuals

    ✓ Peer-reviewed Risk factors Carolina Digital Repository (University of North Carolina at Chapel Hill)

    Key finding: Among 15,346 White, 829 Latino, 637 Black/African American, and 321 Asian individuals, 51% were female, mean age was 75.7 years, 535 (3.8%) resided in ADI 91 to 100 decile, and 61.6% were amyloid PET positive. +2 more findings

Browse the library by subject, with the full score breakdown →